Saad Enterprises, Inc. (doing business as Saad Healthcare)
Outcome
Saad Enterprises, Inc. (Saad Healthcare) paid $3 million to resolve False Claims Act allegations that it knowingly submitted false claims to Medicare for 21 hospice patients in Alabama who were not terminally ill and therefore did not meet the eligibility requirements for the Medicare hospice benefit, covering conduct from 2013 to 2020.
Details
Saad Healthcare — Hospice Billing for Non-Terminally Ill Patients in Alabama (2025)
Outcome: Saad Enterprises, Inc., operating as Saad Healthcare in Mobile and Baldwin County, Alabama, paid $3 million to resolve False Claims Act allegations that it knowingly submitted false claims to Medicare for 21 hospice patients who did not meet the eligibility requirements for the Medicare hospice benefit because they were not terminally ill.
Saad Healthcare is a Mobile, Alabama-based health care organization providing hospice and home health services in the Mobile Bay area.
The settlement, announced February 23, 2025, resolved allegations that between 2013 and 2020 — a seven-year period — Saad submitted or caused the submission of false claims to Medicare for 21 identified patients who did not satisfy Medicare's hospice eligibility standard. Under Medicare statute and regulation, patients are considered terminally ill and hospice-eligible when a physician certifies that the patient's life expectancy is six months or less if the illness runs its normal course. The government alleged that Saad's own records and clinical documentation demonstrated that these 21 patients did not meet that standard, yet Saad continued to certify and bill for their hospice care.
The case was brought by two whistleblowers — Melissa Wolff and Whitney Sims, both former Saad Healthcare employees — who filed a qui tam lawsuit under the False Claims Act. As part of the settlement, the two whistleblowers received $540,000 combined. The settlement was resolved through the U.S. Department of Justice and HHS-OIG.
The case is notable for the long span of alleged misconduct (seven years) relative to the small number of patients at issue (21), suggesting that individual patient eligibility assessments were not being rigorously applied at certification and recertification intervals, and that internal compliance review was insufficient to detect the billing irregularities that two former employees were able to identify and document.
How Crucible Prevents This
Crucible hospice eligibility review controls would require patient-level documentation supporting terminal prognosis at admission and each recertification, with a hard compliance gate preventing claim submission for any patient whose clinical record does not contain a physician attestation supported by documented clinical findings. A small-census hospice compliance module — designed for regional single-market hospice providers who may lack robust internal compliance infrastructure — would provide structured eligibility documentation workflows appropriate to the scale of a provider like Saad Healthcare. Whistleblower intake and investigation controls would ensure former employees with knowledge of billing irregularities have a defined internal reporting pathway before resorting to external qui tam filing.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works